Remove about
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – January

SQA

” The reason: The existing document of the EU GMP Guideline dates back to 2011 and no longer corresponds to the state of the art in various areas or does not consider increasingly important new technologies for the GMP field, according to the EMA. ” The requirements for providers (e.g.,

article thumbnail

SQA Regulatory Surveillance Summary 6 | Monthly Update 2021

SQA

Pilot Program: EMA-FDA Parallel Scientific Advice for Hybrid/Complex Generic Products – General Principles, 15 September 2021. The agencies conduct PSA meetings under the auspices of the confidentiality arrangement between the European Commission, the EMA, and the FDA. European Medicines Agency (EMA). The EMA and the U.S.

FDA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Oversight of AI Software Developed by Health Care Providers

Health Law Advisor

But the question is, to what extent do health care providers need to worry about FDA requirements as they use AI? FDA has been regulating machine learning algorithms used in a clinical context for decades. That’s broad, although arguably not as broad as FDA’s interpretation of it. The allure is obvious. Very brief.

FDA 98
article thumbnail

President Biden Signs End-of-Year Legislation Including Telehealth, Medicare & Medicaid, Mental Health, Pandemic Preparedness, and Other Health Care Provisions

C&M Health Law

trillion spending package, which consists of all 12 fiscal year (FY) 2023 appropriations bills and funds the federal government through September 30, 2023, provides additional assistance to Ukraine, and makes numerous health care policy changes. 117-164 ) (the “Act”)—an approximately $1.7

Medicaid 104
article thumbnail

Terrible Decision Contravenes the Vaccine Act’s Purpose and Would Gut Its Protections

Drug & Device Law

223, 231-33 (2011), holding that the Vaccine Act preempted all design defect claims asserted by claimants who rejected Vaccine Act awards and sought to litigate their claims instead. That’s about the only thing that DeCostanzo got right. “[P]laintiff alleges she suffered a physical injury in the form of defective immunity, among others.

FDA 115
article thumbnail

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

Since the FDA requires pre-approval of any warnings about off-label uses, preemption at some point should have been pre-ordained under the Mensing ( 2011+1 ) independence principle, but off-label use did not really figure in Zofran ’s analysis. There was nothing new or different about them. Another year bites the dust.

FDA 105
article thumbnail

Fourth Circuit Upholds Restrictions on Plaintiff Lawyer Advertising in West Virginia

Drug & Device Law

It is hard to ignore a television ad that sounds like a red flag warning about a medication you are currently taking. It’s harder still sometimes to differentiate between a lawyer ad and public service announcement. Public Service Comm’n , 447 U.S. IMS Health Inc., That’s especially true for drugs and medical devices.